By G HossainPosted on May 12, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Of the 13 programs that the companies will advance, four will come from Hengrui Pharma and four from Bristol Myers Squibb. The remaining five assets will be jointly discovered. BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal Post navigation Trump floats temporary US gas tax halt as pump prices soarBiotech’s IPO tide is finally turning, thanks in part to the recent M&A surge